The morphology and molecular profiles are distinct for each subtype but the recent discoveries of mutations in candidate driver genes, e.g. epidermal growth factor receptor (EGFR), anaplastic lymphoma kinase (ALK), or c-ROS oncogene1 (ROS1), brought a deeper understanding of the lung cancer genome [20]. This evidence concerns the gene ALK and lung cancer.